Radiation is the strongest part of this hospital's cancer program. It began with a problem. Tumors in the lung and liver move every time a patient breathes. To be sure of hitting a moving target, ordinary radiation has to treat a margin of healthy tissue around it. That causes more side effects. It also puts a limit on how high the dose can go, and the dose is what kills the tumor. In 1999 the hospital's radiation oncology group found a way around this. They place small gold markers next to the tumor. X-ray imaging watches those markers all through the treatment. The beam fires only in the moments when the tumor is in position. Two of the hospital's three linear accelerators are fitted with the system. A linear accelerator is the machine that produces the radiation beam.
The same idea was later applied to protons. A proton beam gives up most of its energy at a set depth and then stops. Almost no dose carries on into the tissue behind the tumor. That matters most for tumors sitting close to the spine or the brainstem. It also matters for children, because growing tissue is more easily harmed by stray radiation. The hospital helped develop a spot-scanning proton system that works together with its tumor tracking. Spot scanning paints the beam across the tumor point by point. The work was funded under a Japanese government research program. The hospital describes the result as the first real-time tumor-tracking proton therapy system in the world. It has treated patients on site with it since 2014.
What Japan's national insurance pays for has widened step by step. Childhood cancers were added in 2016. Head and neck tumors, prostate cancer, and bone and soft tissue tumors followed in 2018. In 2022 the list grew to take in some liver, pancreatic, and colorectal cancers that surgery cannot remove or that have come back. Early-stage lung cancer that cannot be operated on was added in 2024. A few other tumor types are treated under Japan's advanced medical treatment framework instead. That framework is not routine insurance coverage, so it changes what a patient pays.
Ordinary radiation runs alongside the proton center. Intensity-modulated radiation therapy shapes the dose so that it bends around organs that must not be harmed. Stereotactic radiosurgery gives a small number of very precise high doses to small tumors. Brachytherapy puts the radiation source inside the body, right next to the tumor. Surgery, chemotherapy, and supportive care are given across the hospital's clinical departments. A Tumor Center ties that work together. It also keeps the cancer registry, which is the record of every cancer case treated here. It runs the pain and symptom care service and the consultation service for patients. Japan requires both of those from a designated cancer care hospital.